Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Telik patents

Patents where

Current Assignee

Name

‌

Telik

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8093231 Sulfonylethyl phosphorodiamidates	Patent 8093231 was granted and assigned to Telik on January, 2012 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8093231	January 10, 2012
‌ US Patent 8198247 Process for and intermediates in the preparation of canfosfamide and its salts	Patent 8198247 was granted and assigned to Telik on June, 2012 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8198247	June 12, 2012
‌ US Patent 8410163 Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors	Patent 8410163 was granted and assigned to Telik on April, 2013 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8410163	April 2, 2013
‌ US Patent 7872134 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidates	Patent 7872134 was granted and assigned to Telik on January, 2011 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	7872134	January 18, 2011
‌ US Patent 7655799 2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates	Patent 7655799 was granted and assigned to Telik on February, 2010 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	7655799	February 2, 2010
‌ US Patent 8716521 Formulations of canfosfamide and their preparation	Patent 8716521 was granted and assigned to Telik on May, 2014 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8716521	May 6, 2014
‌ US Patent 8481781 Formulations of canfosfamide and their preparation	Patent 8481781 was granted and assigned to Telik on July, 2013 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8481781	July 9, 2013
‌ US Patent 7262182 Sulfonylethyl phosphorodiamidates	Patent 7262182 was granted and assigned to Telik on August, 2007 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	7262182	August 28, 2007
‌ US Patent 7129215 Tripeptide and tetrapeptide thioethers	Patent 7129215 was granted and assigned to Telik on October, 2006 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	7129215	October 31, 2006
‌ US Patent 8759303 Compositions and methods for treating myelodysplastic syndrome	Patent 8759303 was granted and assigned to Telik on June, 2014 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8759303	June 24, 2014
‌ US Patent 8841476 Preparation of crystalline ezatiostat hydrochloride ansolvate form D	Patent 8841476 was granted and assigned to Telik on September, 2014 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8841476	September 23, 2014
‌ US Patent 7192918 Tripeptide and tetrapeptide sulfones	Patent 7192918 was granted and assigned to Telik on March, 2007 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	7192918	March 20, 2007
‌ US Patent 8361971 Tablet formulation of ezatiostat	Patent 8361971 was granted and assigned to Telik on January, 2013 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8361971	January 29, 2013
‌ US Patent 8129396 2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors	Patent 8129396 was granted and assigned to Telik on March, 2012 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8129396	March 6, 2012
‌ US Patent 8324426 Formulations of canfosfamide and their preparation	Patent 8324426 was granted and assigned to Telik on December, 2012 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8324426	December 4, 2012
‌ US Patent 8207121 Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound	Patent 8207121 was granted and assigned to Telik on June, 2012 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	8207121	June 26, 2012
‌ US Patent 8334266 Process for and intermediates in the preparation of canfosfamide and its salts		‌ Telik	United States Patent and Trademark Office	8334266	December 18, 2012
‌ US Patent 6998407 Antagonists of MCP-1 function and methods of use thereof	Patent 6998407 was granted and assigned to Telik on February, 2006 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	6998407	February 14, 2006
‌ US Patent 7071231 Naphthalene ureas as glucose uptake enhancers	Patent 7071231 was granted and assigned to Telik on July, 2006 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	7071231	July 4, 2006
‌ US Patent RE38915 Nonpeptide insulin receptor agonists	Patent RE38915 was granted and assigned to Telik on December, 2005 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	RE38915	December 6, 2005
‌ US Patent 6992086 Antagonists of MCP-1 function and methods of use thereof	Patent 6992086 was granted and assigned to Telik on January, 2006 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	6992086	January 31, 2006
‌ US Patent 7029695 Therapeutic compositions containing glutathione analogs	Patent 7029695 was granted and assigned to Telik on April, 2006 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	7029695	April 18, 2006
‌ US Patent 6962926 Antagonist of MCP-1 function, and compositions and methods of use thereof	Patent 6962926 was granted and assigned to Telik on November, 2005 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	6962926	November 8, 2005
‌ US Patent 6894054 Heterocyclic inhibitors of glycine transporter 2	Patent 6894054 was granted and assigned to Telik on May, 2005 by the United States Patent and Trademark Office.	‌ Telik	United States Patent and Trademark Office	6894054	May 17, 2005

24 results

0 selected

24 results

0 selected